POSTMENOPAUSAL HORMONE THERAPY AND THE INCIDENCE OF BREAST CANCER
40 YEAR TRENDS IN POSTMENOPAUSAL HORMONE THERAPY AND THE INCIDENCE OF BREAST CANCER - DISPARITIES EXIST BETWEEN BLACK AND WHITE WOMEN
Apr 15th, 2020
40 YEAR TRENDS IN POSTMENOPAUSAL HORMONE THERAPY AND THE INCIDENCE OF BREAST CANCER - DISPARITIES EXIST BETWEEN BLACK AND WHITE WOMEN
A study presented at the annual meeting of the American Society of Clinical Oncology and published online by the NEJMindicates Exemestane, which is now used to prevent recurrences of breast cancer, can also reduce the risk of it occurring.
“Before the advent of sentinel node biopsy essentially all women with invasive cancer had to have a complete axillary lymph node dissection…."
The American Joint Commission on Cancer or AJCC has a staging system for all cancers including melanoma.
The study out of MD Anderson reporting ‘double the mastectomy rate’ for patients treated with accelerated partial breast irradiation compared to whole breast irradiation, has created a tremendous amount of angst in the lay and medical press.